GlassScriptPhysician profile
Daniela Nissani
NPI 1982381539
$5,819.55
in general payments reported to CMS, 2019-2025
16 companies · $3,132 in 2025
The $3,132 reported for 2025 was more than what 96% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $208 · 2024: $2,480 · 2025: $3,132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,820.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,819.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,173.78 | 2024-2025 | |
| Amgen INC. | $998.76 | 2023-2025 | Otezla, Otezla, Evenity |
| Janssen Biotech, INC. | $948.90 | 2024-2025 | Tremfya, Simponi Aria |
| Ucb, INC. | $660.78 | 2023-2025 | Bimzelx, Cimzia |
| Novartis Pharmaceuticals Corporation | $395.75 | 2024-2025 | |
| Lilly USA, LLC | $388.94 | 2023-2025 | Taltz, Zepbound |
| Mallinckrodt Hospital Products INC. | $366.02 | 2024-2025 | Acthar |
| Ani Pharmaceuticals, INC. | $308.99 | 2024-2025 | Sovuna, Purified Cortrophin Gel |
| Alexion Pharmaceuticals, INC. | $159.70 | 2024-2025 | Strensiq |
| Pfizer INC. | $145.24 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $80.20 | 2024-2025 | Ofev |
| Aurinia Pharma U.S., INC. | $75.34 | 2024-2025 | Lupkynis |
| Radius Health, INC. | $39.71 | 2024-2025 | Tymlos |
| Genzyme Corporation | $31.24 | 2025 | |
| Actelion Pharmaceuticals US, INC. | $28.41 | 2025 | Opsynvi, Uptravi |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $17.79 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniela Nissani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.